Olsalazine

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 259 publications

Physiological and Putative Organic Cation Transporter Expression Response to Alizarin Dye Exposure in Aedes aegypti Mosquitoes.

Physiological and Putative Organic Cation Transporter Expression Response to Alizarin Dye Exposure in Aedes aegypti Mosquitoes.

Journal: Insects

Published: October 13, 2025

Cannabidiol Enhances the Therapeutic Efficacy of Olsalazine and Cyclosporine in a Murine Model of Colitis.

Cannabidiol Enhances the Therapeutic Efficacy of Olsalazine and Cyclosporine in a Murine Model of Colitis.

Journal: International journal of molecular sciences

Published: July 07, 2025

Evaluating rat and canine microbiota models for predicting human colonic prodrug metabolism.

Evaluating rat and canine microbiota models for predicting human colonic prodrug metabolism.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: June 24, 2025

A clinically inspired olsalazine-based metal-organic framework enables a universal nanodrugs platform for diverse disease.

A clinically inspired olsalazine-based metal-organic framework enables a universal nanodrugs platform for diverse disease.

Journal: Journal of colloid and interface science

Published: May 31, 2025

Oral olsalazine/ellagic acid/ZnCl2-modified in situ-forming hydrogels alleviates anxiety/depression-like symptoms and brain neural activity in colitis mice.

Oral olsalazine/ellagic acid/ZnCl2-modified in situ-forming hydrogels alleviates anxiety/depression-like symptoms and brain neural activity in colitis mice.

Journal: Materials today. Bio

Published: April 07, 2025

A Rapid and Reliable Absorbance Assay to Identify Drug-Drug Interactions with Thiopurine Drugs.

A Rapid and Reliable Absorbance Assay to Identify Drug-Drug Interactions with Thiopurine Drugs.

Journal: Metabolites

Published: November 18, 2024

An Innovative Inhibitor with a New Chemical Moiety Aimed at Biliverdin IXβ Reductase for Thrombocytopenia and Resilient against Cellular Degradation.

An Innovative Inhibitor with a New Chemical Moiety Aimed at Biliverdin IXβ Reductase for Thrombocytopenia and Resilient against Cellular Degradation.

Journal: Pharmaceutics

Published: July 29, 2024

Refractory Crohn's Disease Responsive to Dietary Therapy: A Case Report.

Refractory Crohn's Disease Responsive to Dietary Therapy: A Case Report.

Journal: Cureus

Published: May 24, 2024

Discovery of putative inhibitors of human Pkd1 enzyme: Molecular docking, dynamics and simulation, QSAR, and MM/GBSA.

Discovery of putative inhibitors of human Pkd1 enzyme: Molecular docking, dynamics and simulation, QSAR, and MM/GBSA.

Journal: Environmental research

Published: December 26, 2023

Olsalazine pretreatment augments chemosensitivity of gemcitabine in hepatocellular carcinoma.

Olsalazine pretreatment augments chemosensitivity of gemcitabine in hepatocellular carcinoma.

Journal: Journal of biochemical and molecular toxicology

Published: November 30, 2023

Association of intestinal anti-inflammatory drug target genes with psychiatric Disorders: A Mendelian randomization study.

Association of intestinal anti-inflammatory drug target genes with psychiatric Disorders: A Mendelian randomization study.

Journal: Journal of advanced research

Published: November 20, 2023

Rapidly degradable konjac glucomannan hydrogels cross-linked with olsalazine for colonic drug release.

Rapidly degradable konjac glucomannan hydrogels cross-linked with olsalazine for colonic drug release.

Journal: Bio-medical materials and engineering

Published: September 18, 2023

Showing 1-12 of 259

Last Updated: 04/28/2026